SILICONE LYMPHADENOPATHY. LITERATURE REVIEW

D.N. Astakhov, A.A. Zavyalov, N.G. Stepanyants, G.A. Baksiyan, A.V. Aksenenko, I.A. Sheynin

State Scientific Center of the Russian Federation — The A.I. Burnazyan Federal Medical Biophysical Center of the FMBA of Russia, Moscow

 Astakhov Dmitriy N. — Cand. of Sci. (Med.), Surgeon-Oncologist of the Oncological Department of Surgical Methods of Treatment of the State Scientific Center of the Russian Federation — The A.I. Burnazyan Federal Medical Biophysical Center of the FMBA of Russia, Assistant of the Department of Oncology and Radiation Medicine with a course of medical physics of the A.I. Burnazyan Federal Medical Biophysical Center of the FMBA of Russia

23 Marshal Novikov Str., Moscow, 123098, Russian Federation, tel. +7-977-446-77-49, e-mail: astahovy@gmail.com, ORCID ID: 0000-0002-0263-6198, SPIN-код: 6585-4034 

Abstract. Silicone lymphadenopathy is a rare complication in breast implant patients caused by the presence of silicone particles in the lymph nodes with the development of specific granulomatous inflammation. Most often, it occurs against the background of a violation of the integrity of the silicone implant capsule and the spread of silicone into the surrounding tissues. Due to the rarity of this pathology, there are no statistical data on the prevalence of this disease. The literature review presents the data of foreign authors on the clinical picture, diagnosis and treatment of this pathology. Silicon lymphadenopathy is a diagnosis of exclusion, primarily of malignant neoplasms of the breast, since the clinical picture is similar. Silicone lymphadenopathy should be included in the differential diagnosis in patients with enlarged lymph nodes who have previously undergone plastic or oncoplastic surgery using silicone endoprostheses.

Key words: silicone lymphadenopathy, rupture of breast implants, ultrasonic snowstorm syndrome, lymphadenopathy associated with silicone endoprostheses, silicone.